21 October 2016 1 Min Read
Three-way tussle for Pfizer’s Brazilian generics venture, sources say
Generic drugs sales in Brazil expanded 10% last year, slowing from 15% growth in 2014
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In